| Paclitaxel. FY Alqahtani, FS Aleanizy, E El Tahir, HM Alkahtani, BT AlQuadeib Profiles of drug substances, excipients, and related methodology 44, 205-238, 2019 | 116 | 2019 |
| Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats MA Radwan, BT AlQuadeib, L Šiller, MC Wright, B Horrocks Drug Delivery 24 (1), 40-50, 2017 | 93 | 2017 |
| Development and validation of a new HPLC analytical method for the determination of diclofenac in tablets BT Alquadeib Saudi pharmaceutical journal 27 (1), 66-70, 2019 | 83 | 2019 |
| Pharmaceutical evaluation of different shampoo brands in local Saudi market BT AlQuadeib, EKD Eltahir, RA Banafa, LA Al-Hadhairi Saudi pharmaceutical journal 26 (1), 98-106, 2018 | 70 | 2018 |
| Stealth Amphotericin B nanoparticles for oral drug delivery: In vitro optimization BT Al-Quadeib, MA Radwan, L Siller, B Horrocks, MC Wright Saudi pharmaceutical journal 23 (3), 290-302, 2015 | 69 | 2015 |
| Nanoparticles as adjuvants and nanodelivery systems for mRNA-based vaccines IM Alfagih, B Aldosari, B AlQuadeib, A Almurshedi, MM Alfagih Pharmaceutics 13 (1), 45, 2020 | 63 | 2020 |
| Preparation, characterization, and antibacterial activity of diclofenac-loaded chitosan nanoparticles FY Alqahtani, FS Aleanizy, E El Tahir, BT Alquadeib, IA Alsarra, ... Saudi pharmaceutical journal 27 (1), 82-87, 2019 | 56 | 2019 |
| Trastuzumab targeted neratinib loaded poly-amidoamine dendrimer nanocapsules for breast cancer therapy FS Aleanizy, FY Alqahtani, S Seto, N Al Khalil, L Aleshaiwi, M Alghamdi, ... International Journal of Nanomedicine, 5433-5443, 2020 | 37 | 2020 |
| Pharmacokinetics of ketorolac loaded to polyethylcyanoacrylate nanoparticles using UPLC MS/MS for its determination in rats MA Radwan, BT AlQuadeib, NM Aloudah, HYA Enein International journal of pharmaceutics 397 (1-2), 173-178, 2010 | 34 | 2010 |
| Inclusion complexes of piroxicam with β-cyclodextrin derivatives in comparison with the natural β-cyclodextrin 2nd communication: In vitro and in vivo drug availability SA ELKHESHEN, SM AHMED, BT AL-QUADEIB Pharmazeutische Industrie 64 (7), 708-715, 2002 | 19 | 2002 |
| Development of inhalable nanostructured lipid carriers for ciprofloxacin for noncystic fibrosis bronchiectasis treatment AS Almurshedi, HA Aljunaidel, B Alquadeib, BN Aldosari, IM Alfagih, ... International Journal of Nanomedicine, 2405-2417, 2021 | 18 | 2021 |
| Profiles of Drug Substances, Excipients and Related Methodology FY Alqahtani, FS Aleanizy, E El Tahir, HM Alkahtani, BT AlQuadeib Academic Press, 2019 | 18 | 2019 |
| Medicine recalls in Saudi Arabia: a retrospective review of drug alerts (January 2010–January 2019) BT AlQuadeib, IM Alfagih, AH Alnahdi, SM Alharbi, RA Al-ahmari Future Journal of Pharmaceutical Sciences 6, 1-10, 2020 | 15 | 2020 |
| Therapeutic monitoring of amphotericin B in Saudi ICU patients using UPLC MS/MS assay BT Al‐Quadeib, MA Radwan, L Siller, E Mutch, B Horrocks, M Wright, ... Biomedical Chromatography 28 (12), 1652-1659, 2014 | 14 | 2014 |
| Retinal delivery of the protein kinase C-β inhibitor ruboxistaurin using non-invasive nanoparticles of polyamidoamine dendrimers RA Alshammari, FS Aleanizy, A Aldarwesh, FY Alqahtani, WA Mahdi, ... Pharmaceutics 14 (7), 1444, 2022 | 11 | 2022 |
| Stealth Amphotericin B nanoparticles for oral drug delivery BT Al-Quadeib, MA Radwan, L Siller, B Horrocks, MC Wright vitro, 0 | 11 | |
| Formulation of Gelucire®-Based Solid Dispersions of Atorvastatin Calcium: In Vitro Dissolution and In Vivo Bioavailability Study BN Aldosari, AS Almurshedi, IM Alfagih, BT AlQuadeib, MA Altamimi, ... AAPS PharmSciTech 22 (5), 161, 2021 | 10 | 2021 |
| The oral administration of lidocaine HCl biodegradable microspheres: formulation and optimization BT ALQuadeib, EKD Eltahir, MF Alagili International journal of nanomedicine, 857-869, 2020 | 10 | 2020 |
| Preparation, characterization, and antibacterial activity of diclofenacloaded chitosan nanoparticles, Saudi Pharm FY Alqahtani, FS Aleanizy, E El Tahir, BT Alquadeib, IA Alsarra, ... J 27, 82-87, 2019 | 7 | 2019 |
| Paclitaxel. Profiles Drug Subst. Excip. Relat. Methodol., 2019, 44, 205-238 FY Alqahtani, FS Aleanizy, E El Tahir, HM Alkahtani, BT AlQuadeib | 7 | |
